BTI
CVAC

Blue Trust Inc’s CureVac CVAC Stock Holding History

Blue Trust Inc’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,562
Closed -$12.1K – 2557
2024
Q3 		$12.1K Buy
3,562
+3,474
+3,948% +$11.4K ﹤0.01% 2121
2024
Q2 		$267 Buy
+88
New +$288 ﹤0.01% 2651
2024
Q1 		– Sell
-71
Closed – – 2294
2023
Q4 		$0 Buy
+71
New +$385 ﹤0.01% 2526
2023
Q3 		– Sell
-6
Closed – – 2083
2023
Q2 		$0 Buy
+6
New +$54 ﹤0.01% 2106
2023
Q1 		– Sell
-106
Closed -$1K – 2363
2022
Q4 		$1K Buy
106
+64
+152% +$473 ﹤0.01% 2035
2022
Q3 		$1K Buy
+42
New +$490 ﹤0.01% 1903

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Blue Trust Inc's CVAC Position: Q4 2024 in Review

Blue Trust Inc sold out of CureVac (CVAC) in Q4 2024, closing a stake of 3,562 shares — an estimated $12.1K sold.

Blue Trust Inc first reported a position in CVAC in Q3 2022 and held it in 6 quarters. The position peaked at $12.1K in Q3 2024. 75 funds tracked by Wall St. Rank hold CVAC as of Q4 2024.

  • Blue Trust Inc reported no remaining CureVac position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 3,562 CureVac shares in Q4 2024, an estimated $12.1K.
  • Blue Trust Inc first reported a position in CureVac in Q3 2022 and held it in 6 quarters.
  • Blue Trust Inc's CureVac position peaked at $12.1K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held CureVac as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.